Procurement of an Assay to Measure Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in Human Blood Samples for the UK Biobank study of seroprevalence of Covid-19

avviso di aggiudicazione di appalto

Di seguito le informazioni riguardanti l'avviso 2020/S 120-293646 dell'anno 2020.

Amministrazione aggiudicatrice UK Biobank Ltd
Greater Manchester (UKD3) altri enti
Tipo di amministrazione aggiudicatrice Organismo di diritto pubblico
Principali settori di attività Salute
Tipo di appalto Servizi
Codice CPV principale
Luogo di esecuzione Greater Manchester South East (UKD35) altri
Paese EN; - country: UK
Tipo di documento Avviso di aggiudicazione
Procedura Procedura negoziata senza previa indizione di gara
Tipo di offerta Non applicabile
Criteri di aggiudicazione Non applicabile
Regolamento Non specificato
Data di pubblicazione 2020-06-24 00:00:00
Scadenza 2020-09-30 00:00:00
Valori 1˙560˙000.00 GBP (totale appalto)

Controlla i dati grezzi

Guarda i dati grezzi come da XML fornito dal TED.

TECHNICAL_SECTION

1 RECEPTION_ID: 20-302446-001

1 DELETION_DATE: 20200930

1 FORM_LG_LIST: EN

1 COMMENTS: From Convertor

LINKS_SECTION

1 XML_SCHEMA_DEFINITION_LINK

1 OFFICIAL_FORMS_LINK

1 FORMS_LABELS_LINK

1 ORIGINAL_CPV_LINK

1 ORIGINAL_NUTS_LINK

CODED_DATA_SECTION

1 REF_OJS

2 COLL_OJ: S

2 NO_OJ: 120

2 DATE_PUB: 20200624

1 NOTICE_DATA

2 NO_DOC_OJS: 2020/S 120-293646

2 URI_LIST

3 --- URI_DOC   value: http://ted.europa.eu/udl?uri=TED:NOTICE:293646-2020:TEXT:EN:HTML

2 LG_ORIG: EN

2 ISO_COUNTRY

INFO: UK

2 IA_URL_GENERAL: http://www.ukbiobank.ac.uk

2 ORIGINAL_CPV: Medical analysis services

INFOCODE: 85148000

2 ORIGINAL_CPV: Miscellaneous health services

INFOCODE: 85140000

2 VALUES

3 --- VALUE   value: 1560000

1 CODIF_DATA

2 DS_DATE_DISPATCH: 20200622

2 AA_AUTHORITY_TYPE: Body governed by public law

INFOCODE: 6

2 TD_DOCUMENT_TYPE: Contract award notice

INFOCODE: 7

2 NC_CONTRACT_NATURE: Services

INFOCODE: 4

2 PR_PROC: Negotiated without a prior call for competition

INFOCODE: T

2 RP_REGULATION: Not specified

INFOCODE: Z

2 TY_TYPE_BID: Not applicable

INFOCODE: 9

2 AC_AWARD_CRIT: Lowest price

INFOCODE: 1

2 MA_MAIN_ACTIVITIES: Health

INFOCODE: H

2 HEADING: 08C03

2 INITIATOR: 08

TRANSLATION_SECTION

1 ML_TITLES

2 ML_TI_DOC

3 --- TI_CY   value: Обединено кралство

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Услуги, свързани с медицински анализи

2 ML_TI_DOC

3 --- TI_CY   value: Spojené království/Velká Británie

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Lékařská analýza

2 ML_TI_DOC

3 --- TI_CY   value: Forenede Kongerige, Det

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Medicinske analyser

2 ML_TI_DOC

3 --- TI_CY   value: das Vereinigte Königreich

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Medizinische Analysedienste

2 ML_TI_DOC

3 --- TI_CY   value: Ηνωμένο Βασίλειο

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Υπηρεσίες ιατρικών αναλύσεων

2 ML_TI_DOC

3 --- TI_CY   value: United Kingdom

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Medical analysis services

2 ML_TI_DOC

3 --- TI_CY   value: Reino Unido

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Servicios de análisis médicos

2 ML_TI_DOC

3 --- TI_CY   value: Suurbritannia / Ühendkuningriik

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Meditsiinilise analüüsi teenused

2 ML_TI_DOC

3 --- TI_CY   value: Yhdistynyt kuningaskunta

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Lääketieteelliset analyysipalvelut

2 ML_TI_DOC

3 --- TI_CY   value: Royaume-Uni

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Services d'analyses médicales

2 ML_TI_DOC

3 --- TI_CY   value: Ríocht Aontaithe, an

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Medical analysis services

2 ML_TI_DOC

3 --- TI_CY   value: Ujedinjena Kraljevina

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Usluge medicinskih analiza

2 ML_TI_DOC

3 --- TI_CY   value: Egyesült Királyság

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Egészségügyi elemzési szolgáltatások

2 ML_TI_DOC

3 --- TI_CY   value: Regno Unito

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Servizi di analisi mediche

2 ML_TI_DOC

3 --- TI_CY   value: Jungtinė Karalystė, Didžioji Britanija

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Medicininės analizės paslaugos

2 ML_TI_DOC

3 --- TI_CY   value: Apvienotā Karaliste

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Medicīniskās analīzes pakalpojumi

2 ML_TI_DOC

3 --- TI_CY   value: Ir-Renju Unit

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Servizzi ta' analiżi medika

2 ML_TI_DOC

3 --- TI_CY   value: Verenigd Koninkrijk

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Medische analysediensten

2 ML_TI_DOC

3 --- TI_CY   value: Zjednoczone Królestwo

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Usługi analizy medycznej

2 ML_TI_DOC

3 --- TI_CY   value: Reino Unido

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Serviços de análises clínicas

2 ML_TI_DOC

3 --- TI_CY   value: Regatul Unit

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Servicii de analize medicale

2 ML_TI_DOC

3 --- TI_CY   value: Spojené kráľovstvo

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Lekárske rozbory

2 ML_TI_DOC

3 --- TI_CY   value: Združeno kraljestvo

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Storitve medicinskih analiz

2 ML_TI_DOC

3 --- TI_CY   value: Förenade kungariket

3 --- TI_TOWN   value: Stockport

3 TI_TEXT

L: 4 --- key: (P)   value: Medicinsk analys

1 ML_AA_NAMES

2 AA_NAME: UK Biobank Ltd

FORM_SECTION

1 NOTICE_UUID: c62c59e3-132b-4006-8b2d-63b9a6de3823

1 F03_2014

2 LEGAL_BASIS

INFO: 32014L0024

2 CONTRACTING_BODY

3 ADDRESS_CONTRACTING_BODY

L: 4 --- key: (OFFICIALNAME)   value: UK Biobank Ltd

L: 4 --- key: (ADDRESS)   value: 1-2 Spectrum Way, Adswood

L: 4 --- key: (TOWN)   value: Stockport

L: 4 --- key: (POSTAL_CODE)   value: SK3 0SA

INFO4: UK

4 COUNTRY

L: 4 --- key: (PHONE)   value: +44 1614755386

L: 4 --- key: (E_MAIL)   value: andrea.howard@ukbiobank.ac.uk

L: 4 --- key: (URL_GENERAL)   value: http://www.ukbiobank.ac.uk

L: 4 --- key: (URL_BUYER)   value: https://www.mytenders.co.uk/search/Search_AuthProfile.aspx?ID=AA25607

3 CA_TYPE

3 CA_ACTIVITY

2 OBJECT_CONTRACT

3 TITLE

L: 4 --- key: (P)   value: Procurement of an Assay to Measure Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in Human Blood Samples for the UK Biobank study of seroprevalence of Covid-19

3 --- REFERENCE_NUMBER   value: UKBB011

3 CPV_MAIN

4 CPV_CODE

3 TYPE_CONTRACT

3 SHORT_DESCR

L: 4 --- key: (P)   value: UK Biobank is conducting a study of seroprevalence of Covid-19 in the population of up to 20 000 of its participants and their adult children and grandchildren (the ‘Study’). The study (which is funded by the Department of Health and Social Care) aims to collect blood samples from study participants each month for an initial period of 6 months and measure these samples to assess the extent of previous infection with the SARS‐CoV‐2 coronavirus (by measuring blood antibodies) in different locations and age groups across the UK. In order to enable the study, UK Biobank needed a supplier to provide an assay which could be used to measure blood antibodies. There was an urgent need to identify a supplier of an assay to enable UK Biobank to design the study – in particular the method of blood collection – to enable the study to start without delay. The study needed to start as soon as possible to enable UK Biobank to report the assay results to DHSC to assist the DHSC in its monitoring of Covid-19 in the population as part of its urgent public health response to the Covid-19 pandemic. Whilst it is UK Biobank that has entered into the contract directly with the assay supplier, the DHSC will be remunerating the supplier direct (rather than payment being made through UK Biobank)

3 --- VAL_TOTAL   value: 1560000

3 NO_LOT_DIVISION

3 OBJECT_DESCR

4 CPV_ADDITIONAL

5 CPV_CODE

4 SHORT_DESCR

5 P: Procurement of an assay to measure severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in human blood samples.

4 AC

5 AC_PRICE

4 NO_OPTIONS

4 NO_EU_PROGR_RELATED

2 PROCEDURE

3 PT_AWARD_CONTRACT_WITHOUT_CALL

4 D_ACCORDANCE_ARTICLE

5 D_EXTREME_URGENCY

4 D_JUSTIFICATION

5 P: UK Biobank (‘UKB’) has relied on Regulation 32(2)(c) of the Public Contracts Regulations 2015 (‘PCR 2015’) to make a direct award due to extreme urgency. In relying on this ground UKB has considered the guidance set out in the Cabinet Office information note ‘Procurement Policy Note – Responding to Covid-19 Information Note PPN 01/20 (March 020)’. The Covid-19 pandemic is so novel that the consequences were unforeseeable. Confirmation as to the need to undertake the Study as a matter of urgency was only confirmed to UKB on 23 April 2020 (with the study starting and blood collection kits being mailed out on 20 May 2020). This urgency did not provide UKB with sufficient time to comply with the usual/accelerated timescales in the PCR 2015 as it was imperative to ascertain which assay was being used in order to design the blood collection methods for the study and get the study started. The urgency UKB is responding to could not have been foreseen and is not due to UKB’s delay in acting. Reliance on Regulation 32(2)(2)(c) was imperative to enable UKB to design and start the study (in the interests of public health as part of the Government’s testing programme ‘Coronavirus (Covid-19) scaling up our testing programmes’ It was not practical to consider entering into a very short term services contract with the appointed contractor whilst a competitive accelerated process was run for the remainder of the study – the same assay needs to be used on all the samples in the study to ensure consistency and reliability of the data being generated and analysed for the purposes of the study.

3 CONTRACT_COVERED_GPA

2 AWARD_CONTRACT

3 AWARDED_CONTRACT

L: 4 --- key: (DATE_CONCLUSION_CONTRACT)   value: 2020-06-05

4 TENDERS

5 NB_TENDERS_RECEIVED: 1

5 NB_TENDERS_RECEIVED_SME: 0

5 NB_TENDERS_RECEIVED_OTHER_EU: 0

5 NB_TENDERS_RECEIVED_NON_EU: 0

5 NB_TENDERS_RECEIVED_EMEANS: 1

4 CONTRACTORS

5 NO_AWARDED_TO_GROUP

5 CONTRACTOR

6 ADDRESS_CONTRACTOR

OFFICIALNAME: The Chancellor Masters and Scholars of The University of Oxford

ADDRESS: University Offices, Wellington Square

TOWN: Oxford

POSTAL_CODE: OX1 2JD

7 COUNTRY

6 NO_SME

4 VALUES

5 VAL_TOTAL: 1560000

2 COMPLEMENTARY_INFO

3 INFO_ADD

L: 4 --- key: (P)   value: (MT Ref:219946)

3 ADDRESS_REVIEW_BODY

L: 4 --- key: (OFFICIALNAME)   value: The High Court

L: 4 --- key: (TOWN)   value: London

INFO4: UK

4 COUNTRY

3 --- DATE_DISPATCH_NOTICE   value: 2020-06-22

11+1